S-(-)-IBZM (50 mg)

S-(-)-IBZM
Product No.： IBZM-95
CAS No.： 84226-06-2

Storage and Stability

• Store the product at -20 ℃, protected from light.
• Short-term storage at higher temperatures does not affect product quality.

Notes

• Complete documentation - Certificates of Analysis including testing reports of ¹H-NMR and HPLC spectra for each shipment
• Customized dispensing available

Research

• Kung H.F. et al. Dopamine D-2 receptor Imaging Radiopharmaceuticals: Synthesis, Radiolabeling and in Vitro binding of R(+)- and S(-)-3-iodo-2-hydroxy-6-methoxy- N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide. J. Med. Chem. 1988, 31, 1039-1043.
• Cordes et al., Initial experience with SPECT examinations using [¹²³I]IBZM as a D2-dopamine receptor antagonist in Parkinson’s disease Eur. J. Radiol. 1991, 12, 182.
• Innis R.B. et al. Amphetamine-stimulated dopamine release competes in vivo for [¹²³I]IBZM binding to the D2 receptor in nonhuman primates. Synapse 1992, 10, 177.
• Ichise M. et al. Iodine-123-IBZM dopamine D2 receptor and technetium-99m-HMPAO brain perfusion SPECT in the evaluation of patients with and subjects at risk for Huntington’s disease J. Nucl. Med. 1993, 34, 1274.